Tech Company Financing Transactions

Epic Sciences Funding Round

Hermed Capital, Altos Ventures and Domain Associates participated in a $40 million Series D capital raise for Epic Sciences. The round was announced on 4/28/2017.

Transaction Overview

Company Name
Epic Sciences
Announced On
4/28/2017
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series D
Investors

Hermed Capital (Lead Investor) (Jerry Xiao)

Altos Ventures

Domain Associates (Kim Kamdar)

Genomic Health

Pagoda Investment

Reach Tone Limited

RusnanoMedInvest (Evgeny Zaytsev)

Sabby Capital

VI Partners

Proceeds Purpose
Epic plans to use the funds to accelerate clinical studies for oncology tests in the company's pipeline as well as enhance its proprietary No Cell Left Behind technology to include characterization of rare leukocyte cell populations with next generation digital imaging and big data analytics.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9381 Judicial Dr. 200
La Jolla, CA 92121
USA
Phone
(858) 356-6610
Website
www.epicsciences.com
Email Address
[email protected]
Overview
Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.
Profile
Epic Sciences LinkedIn Company Profile
Social Media
Epic Sciences Company Twitter Account
Company News
Epic Sciences News
Facebook
Epic Sciences on Facebook
YouTube
Epic Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Lloyd Sanders
  Lloyd Sanders LinkedIn Profile  Lloyd Sanders Twitter Account  Lloyd Sanders News  Lloyd Sanders on Facebook
Chief Financial Officer
Joel Smith
  Joel Smith LinkedIn Profile  Joel Smith Twitter Account  Joel Smith News  Joel Smith on Facebook
Chief Medical Officer
Richard Wenstrup
  Richard Wenstrup LinkedIn Profile  Richard Wenstrup Twitter Account  Richard Wenstrup News  Richard Wenstrup on Facebook
Chief Technical Officer
Chockalingam Palaniappan
  Chockalingam Palaniappan LinkedIn Profile  Chockalingam Palaniappan Twitter Account  Chockalingam Palaniappan News  Chockalingam Palaniappan on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/28/2017: Domo venture capital transaction
Next: 4/28/2017: Recombinetics venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.